Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Obese women with PCOS are more likely to have fatty liver disease.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.